Answers are grounded in this paper and cite their sources.
Demonstrates the role of LGALS3 in inducing ferroptosis in CKD vascular calcification, suggesting new therapeutic targets.
Interestingly, the Cys1205 residue of BRG1 is involved in the interaction between ABHD17 and BRG1 and affects its synergistic procalcification effect on VSMCs.Conclusion: Protein S-palmitoylation modification is closely associated with vascular calcification in CKD, and ABHD17B might be a novel potential target for the prevention and treatment of vascular calcification in CKD.I have potential conflict of interest to disclose.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: